Company intelligence / Profile preview

Stem Cell Pharmaceuticals

Orlando, Florida, United States

Ownership: Private
Development stage: Other

Overview

Stem Cell Pharmaceutical is a biotechnology company focused on the development and commercialization of advanced stem cell-based therapies. The company specializes in utilizing mesenchymal stem cells (MSCs) derived from various sources to treat degenerative conditions and promote tissue regeneration. Their primary clinical focus includes orthopedic applications such as osteoarthritis and degenerative disc disease, as well as wound care and sexual health. Stem Cell Pharmaceutical aims to provide minimally invasive alternatives to traditional surgical interventions through its regenerative medicine portfolio.

Therapeutic areas: NeurologyMen's HealthRheumatologyDermatology
Modalities: Stem cell therapyCell therapy
Industry: Biotech

Beyond the preview

Go deeper on Stem Cell Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stem Cell Pharmaceuticals.

Explore the full profile